LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 56.24 | 17.25 | 1411 | 4929 | 0.2863 | 0.7157 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 56.24 | 17.25 | 1437 | 4929 | 0.2915 | 0.7196 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 56.24 | 17.25 | 1879 | 4929 | 0.3812 | 0.7770 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 56.24 | 17.25 | 1900 | 4929 | 0.3855 | 0.7794 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 58.21 | 17.25 | 1475 | 4942 | 0.2984 | 0.7246 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 58.21 | 17.25 | 1496 | 4942 | 0.3027 | 0.7276 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 58.21 | 17.25 | 1945 | 4942 | 0.3935 | 0.7841 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 58.21 | 17.25 | 1972 | 4942 | 0.3990 | 0.7871 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 60.18 | 17.25 | 1531 | 5031 | 0.3043 | 0.7295 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 60.18 | 17.25 | 1560 | 5031 | 0.3101 | 0.7335 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 60.18 | 17.25 | 1985 | 5031 | 0.3945 | 0.7852 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 60.18 | 17.25 | 2017 | 5031 | 0.4009 | 0.7887 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 63.15 | 17.25 | 1574 | 5061 | 0.3110 | 0.7344 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 63.15 | 17.25 | 1601 | 5061 | 0.3163 | 0.7380 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 63.15 | 17.25 | 2064 | 5061 | 0.4078 | 0.7927 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 63.15 | 17.25 | 2090 | 5061 | 0.4130 | 0.7954 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 65.12 | 17.25 | 1617 | 5095 | 0.3174 | 0.7390 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 65.12 | 17.25 | 1655 | 5095 | 0.3248 | 0.7439 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 65.12 | 17.25 | 2110 | 5095 | 0.4141 | 0.7963 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 65.12 | 17.25 | 2138 | 5095 | 0.4196 | 0.7992 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 67.09 | 17.25 | 1680 | 5221 | 0.3218 | 0.7429 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 67.09 | 17.25 | 1711 | 5221 | 0.3277 | 0.7468 | MN20160310_N02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 67.09 | 17.25 | 2148 | 5221 | 0.4114 | 0.7957 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 67.09 | 17.25 | 2170 | 5221 | 0.4156 | 0.7979 | MN20160310_N02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 69.06 | 17.25 | 1736 | 5242 | 0.3311 | 0.7492 | MN20160310_N02 | F03 |